Sirolimus in crystalline form
provides controlled and
sustained drug elution in tissue
Product available
through key
distribution partners
Our proprietary technology utilizes supercritical fluids, which allow for prolonged therapeutic drug dosing after polymer absorption.
Read more...Our products are designed to make clinically meaningful improvements in patient outcomes, and are available in select countries around the world.
Read more...Our ongoing clinical trials are designed to confirm the effectiveness of our technology in interventional cardiology.
Read more...Watch the TCTMD panel discussion that addresses the question: Are All Bioabsorbable Stent Coatings the Same? Hear expert opinion on a novel approach that helps reduce disease progression and TLR catch-up phenomenon.
Panelists include Alexandra Lansky, M.D., Robbert de Winter, M.D., Ph.D., Elazer Edelman, M.D., Ph.D., and Martin Leon, M.D.
Watch video...
